The U.S. Food and Drug Administration announced the nationwide recall of Aspire36 and Aspire Lite dietary supplements due to a safety issue.
The FDA said Palo Alto Labs of Port St. Lucie, Fla., initiated the voluntary recall after being informed by the FDA that lab analysis revealed the products contained Aildenafil in trace amounts and Dimethyl sildenafil thione (sulfoaildenafil), a purported analog of Sildenafil, an approved drug used as treatment for male erectile dysfunction. The FDA said the presence of those chemicals might post a safety hazard to consumers by interacting with nitrates found in some prescription drugs and might lower blood pressure to dangerous levels.
Aspire36 and Aspire Lite are sold in blister packs containing one liquid capsule or a bottle containing either three or 12 liquid capsules.
The company said consumers can call 877-240-3340 for instructions on the return and refund process.
Copyright 2008 by United Press International
Explore further: Errata frequently seen in medical literature